Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137585) titled 'A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity' on Aug. 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Hoffmann-La Roche
Condition:
Type 2 Diabetes Mellitus
Obesity
Overweight
Intervention:
Drug: Placebo
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: August 14, 2025
Tar...